Hepatotoxic Agents, Less DILI Concern

All categories
DBCAT006072Pharmacologic class

Drugs classified as Less-DILI-Concern in the FDA DILIrank 2.0 dataset. These agents have a verified causal association with drug-induced liver injury, but at a lower labeled severity than Most-DILI-Concern agents. A DrugBank category of 349 drugs. 349 of them are approved.

Part of
Hepatotoxic Agents
Drugs

and 324 more with a free account

What you can answer from here — as of July 02, 2026

349DrugsEach linked to its full drug card
Sign in
687Drug targetsEvery drug–target pair in the class, with bond type
Sign in
235,930Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
59Routes of administrationHow the drugs in this class are given
Sign in
1ReferenceSupporting the category definition
Sign in

Which targets do Hepatotoxic Agents, Less DILI Concern share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In